160
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Early management of COPD: where are we now and where do we go from here? A Delphi consensus project

, , , , , , , , , , , , & show all
Pages 353-360 | Published online: 04 Feb 2019

References

  • GOLD [homepage on the Internet]From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: http://goldcopd.orgAccessed June 2018
  • World Health Statistics2008 Available from: http://www.who.int/whosis/whostat/EN_WHS08_Full.pdfAccessed June 2018
  • BuistASVollmerWMMcBurnieMAWorldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiativeInt J Tuberc Lung Dis200812770370818544191
  • AnzuetoAImpact of exacerbations on COPDEur Respir Rev20101911611311820956179
  • WelteTVogelmeierCPapiACOPD: early diagnosis and treatment to slow disease progressionInt J Clin Pract201569333634925363328
  • ZhouYZhongNSLiXTiotropium in early-stage chronic obstructive pulmonary diseaseN Engl J Med20173771092393528877027
  • DecramerMMiravitllesMPriceDNew horizons in early stage COPD – improving knowledge, detection and treatmentRespir Med2011105111576158721239156
  • British Lung Foundation [homepage on the Internet]Invisible livesChronic obstructive lung disease (COPD) – finding the missing millions2010 Available from: http://www.lunguk.orgAccessed April 2013
  • MurphyMKBlackNALampingDLConsensus development methods, and their use in clinical guideline developmentHealth Technol Assess199823188
  • FinkAKosecoffJChassinMBrookRHConsensus methods: characteristics and guidelines for useAm J Public Health19847499799836380323
  • LinstoneHTuroffMThe Delphi Method Techniques and ApplicationsReading, MAAddison-Wesley Publishing Company19751616
  • JonesJHunterDConsensus methods for medical and health services researchBMJ199531170013763807640549
  • MiravitllesMSoler-CataluñaJJAlcázarBViejoJLGarcía-RíoFFactors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensusPulm Pharmacol Ther2018489710329031616
  • PadrãoEAraújoDTodo BomAAsthma-COPD overlap: a Portuguese surveyPulmonology2018243174181
  • DapariRIsmailHIsmailRIsmailNHApplication of fuzzy Delphi in the selection of COPD risk factors among steel industry workersTanaffos2017161465228638424
  • HillATHaworthCSAlibertiSPulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical researchEur Respir J2017496170005128596426
  • PlazaVÁlvarezFCalleMConsensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)Arch Bronconeumol2017538443449 English, Spanish28495077
  • NinaneVCorhayJLGermonpréPInhaled treatment of COPD: a Delphi consensus statementInt J Chron Obstruct Pulmon Dis20171279380128293106
  • RheeCKKimKYoonHKNatural course of early COPDInt J Chron Obstruct Pulmon Dis20171266366828255237
  • FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
  • AnthonisenNRSkeansMAWiseRALung Health Study Research GroupThe effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med200514223323915710956
  • Soler-CataluñaJJMartínez-GarcíaMARomán SánchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • DecramerMDahlRKornmannOKornSLawrenceDMcBryanDEffects of long-acting bronchodilators in COPD patients according to COPD severity and ICS useRespir Med2013107222323223219347
  • WelteTChapmanKRMagnussenHMiravitllesMCurrent thinking and new paradigm for COPDRespir Med201611212612726895809
  • ArielAAltrajaABelevskiyAInhaled therapies in patients with moderate COPD in clinical practice: current thinkingInt J Chron Obstruct Pulmon Dis201813455629317810
  • MaltaisFDennisNChanCKRationale for earlier treatment in COPD: a systematic review of published literature in mild-to-moderate COPDCOPD20131017910323272663
  • QaseemAWiltTJWeinbergerSEAmerican College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory SocietyDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
  • van den BoomGRutten-van MölkenMPTirimannaPRvan SchayckCPFolgeringHvan WeelCAssociation between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programmeEur Respir J199811167729543272
  • d’AndiranGSchindlerCLeuenbergerPThe absence of dyspnoea cough and wheezing. A reason for undiagnosed airflow obstruction?Swiss Med Wkly200613642543316862462
  • ShinCLeeSAbbottRDRespiratory symptoms and undiagnosed airflow obstruction in middle-aged adults: the Korean Health and Genome StudyChest200412641234124015486387
  • LuMYaoWZZhongNSAsymptomatic patients of chronic obstructive pulmonary disease in ChinaChin Med J (Engl)2010123121494149920819499
  • BrandPLRijckenBSchoutenJPKoëterGHWeissSTPostmaDSPerception of airway obstruction in a random population sample. Relationship to airway hyperresponsiveness in the absence of respiratory symptomsAm Rev Respir Dis199214623964011489130
  • van der MolenTWillemseBWSchokkerSTen HackenNHPostmaDSJuniperEFDevelopment, validity and responsiveness of the Clinical COPD QuestionnaireHealth Qual Life Outcomes200311312773199
  • CazzolaMBrusascoVCentanniSProject PriMo: sharing principles and practices of bronchodilator therapy monitoring in COPD: a consensus initiative for optimizing therapeutic appropriateness among Italian specialistsPulm Pharmacol Ther201326221822823147424
  • CazzolaMSantusPCastagnaFAddition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPDRespir Med200296643944312117044
  • MakGHananiaNANew bronchodilatorsCurr Opin Pharmacol201212323824522445544
  • CazzolaMTashkinDPCombination of formoterol and tiotropium in the treatment of COPD: effects on lung functionCOPD20096540441519863370
  • CazzolaMMolimardMThe scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPDPulm Pharmacol Ther201023425726720381630
  • ÁghTInotaiAMészárosÁFactors associated with medication adherence in patients with chronic obstructive pulmonary diseaseRespiration201182432833421454953